MedTrace Logo

Treating Self Injurious Behavior: A Novel Brain Stimulation Approach

NCT04244786 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 13

Last updated 2024-07-03

Study results available
· View outcomes & findings →

Summary

The purpose of this study is to explore the tolerability and effectiveness of transcranial direct current stimulation (tDCS) as a potential treatment for non-suicidal self-injury (NSSI). Individuals who engage in frequent NSSI will be randomized to 12 administrations of an active vs. inactive form of tDCS, paired with an Attention Training Technique task, over a two-week period. Functional MRI may be performed before and after this two week period. NSSI urges and behaviors will be monitored before, during, and after the period of tDCS administrations.

Conditions

  • Self-Injurious Behavior
  • Self Harm
  • Self-injury
  • Self-inflicted Injury
  • Self Injurious Behavior Without Suicidal Intent
  • Non-Suicidal Self Injury
  • Non Suicidal Self Inflicted Injury
  • Cutting
  • Depression
  • Bipolar Disorder
  • Borderline Personality Disorder

Interventions

DEVICE

Transcranial direct current stimulation

tDCS is a low-cost, portable, well-tolerated, non-invasive form of brain stimulation that delivers a low current to a specific area of the brain via electrodes.

OTHER

No intervention

No intervention for participants who discontinued prior to randomization

Sponsors & Collaborators

  • New York State Psychiatric Institute

    lead OTHER

Principal Investigators

  • Jeffrey M Miller, MD · NYSPI

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
QUADRUPLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
60 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2019-10-01
Primary Completion
2022-07-29
Completion
2022-07-29
FDA Device
Yes

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04244786 on ClinicalTrials.gov